The latest English literature on evidence-based medicine (EBM) covers a range of clinical topics and treatment approaches. For example, a 2024 study on statins found that these drugs can reduce cardiovascular disease risk by over 20% in patients aged 75 and older with high cholesterol, further supporting their use in the elderly population.
Additionally, BMJ Evidence-Based Medicine recently published an article analyzing the impact of COVID-19 on EBM practices, highlighting the need to integrate mechanistic evidence into decision-making to address the limitations of relying solely on randomized controlled trials. Equally valuable, ACP Journal Club provides monthly systematic reviews summarizing clinical evidence, offering internists up-to-date treatment guidelines and decision-making support based on the latest research.
For further exploration of these EBM publications, resources such as BMJ Evidence-Based Medicine and ACP Journal Club are recommended.
References:
1. Xu, W., Lee, A. L., Lam, C. L. K., Danaei, G., & Wan, E. Y. F. (2024). Benefits and risks associated with statin therapy for primary prevention in old and very old adults. Annals of Internal Medicine, 177(6), 701. Available at: https://www.acponline.org 
2. BMJ Evidence-Based Medicine. (2024). Analyzing the impact of COVID-19 on EBM practices and the need for mechanistic evidence. Available at: https://ebm.bmj.com 
3. ACP Journal Club. (2024). Monthly systematic reviews and clinical evidence updates. American College of Physicians. Available at: https://www.acponline.org